Tandem Diabetes Care, Inc. (LON:0M0F)
London
· Delayed Price · Currency is GBP · Price in USD 16.98
+0.31 (1.89%)
At close: Apr 24, 2025
Tandem Diabetes Care Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -96.03 | -222.61 | -94.59 | 15.57 | -34.38 | Upgrade
|
| Depreciation & Amortization | 16.61 | 15.72 | 14.33 | 13.85 | 10.45 | Upgrade
|
| Other Amortization | 2.09 | 2.2 | 1.9 | 1.73 | 10.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 78.75 | 31.04 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.32 | 3.59 | 4.19 | 0.37 | -1.3 | Upgrade
|
| Loss (Gain) on Equity Investments | 2.05 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 101.38 | 88.08 | 84.92 | 60.75 | 58.43 | Upgrade
|
| Provision & Write-off of Bad Debts | 9.98 | 5.54 | 4.78 | 2.33 | 3.02 | Upgrade
|
| Other Operating Activities | 2.24 | 14.61 | 8.56 | 2.4 | 14.94 | Upgrade
|
| Change in Accounts Receivable | -20.8 | 4.28 | -7.83 | -30.98 | -38.84 | Upgrade
|
| Change in Inventory | 5.81 | -46.05 | -42.45 | -4.95 | -15.36 | Upgrade
|
| Change in Accounts Payable | -2.39 | -4.86 | 24.49 | 10.28 | 1.12 | Upgrade
|
| Change in Unearned Revenue | -34.74 | 21.53 | 8.36 | 10.61 | 7.03 | Upgrade
|
| Change in Other Net Operating Assets | 40.33 | 7.43 | 12.78 | 29.42 | 9.46 | Upgrade
|
| Operating Cash Flow | 24.23 | -31.81 | 50.46 | 111.36 | 24.67 | Upgrade
|
| Operating Cash Flow Growth | - | - | -54.68% | 351.41% | -41.13% | Upgrade
|
| Capital Expenditures | -19.23 | -26.8 | -34.1 | -14.18 | -27.41 | Upgrade
|
| Cash Acquisitions | - | -69.5 | -25.72 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -9.33 | -4.89 | Upgrade
|
| Investment in Securities | -4.25 | 10.56 | 92.99 | -163.37 | -263.76 | Upgrade
|
| Investing Cash Flow | -23.48 | -85.74 | 33.17 | -186.88 | -296.06 | Upgrade
|
| Long-Term Debt Issued | 306.85 | - | - | - | 278.69 | Upgrade
|
| Long-Term Debt Repaid | -246.12 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 60.73 | - | - | - | 278.69 | Upgrade
|
| Issuance of Common Stock | - | 4.18 | 17.47 | 51.93 | 69.82 | Upgrade
|
| Repurchase of Common Stock | -36.73 | - | - | - | - | Upgrade
|
| Other Financing Activities | -15.63 | -0.07 | -0.59 | - | -34.07 | Upgrade
|
| Financing Cash Flow | 8.37 | 4.11 | 16.88 | 51.93 | 314.44 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.26 | -0.21 | 0.83 | 0.15 | 0.39 | Upgrade
|
| Net Cash Flow | 10.37 | -113.65 | 101.34 | -23.43 | 43.44 | Upgrade
|
| Free Cash Flow | 4.99 | -58.61 | 16.37 | 97.18 | -2.74 | Upgrade
|
| Free Cash Flow Growth | - | - | -83.16% | - | - | Upgrade
|
| Free Cash Flow Margin | 0.53% | -7.84% | 2.04% | 13.83% | -0.55% | Upgrade
|
| Free Cash Flow Per Share | 0.08 | -0.90 | 0.26 | 1.51 | -0.04 | Upgrade
|
| Cash Interest Paid | 3.08 | 7.57 | 4.31 | 4.31 | 2.71 | Upgrade
|
| Cash Income Tax Paid | 3.1 | 1.92 | 0.41 | 0.26 | 0.18 | Upgrade
|
| Levered Free Cash Flow | 38.15 | -35.7 | 8.76 | 55.93 | -17.55 | Upgrade
|
| Unlevered Free Cash Flow | 40.69 | -31.72 | 10.75 | 57.98 | -19.65 | Upgrade
|
| Change in Net Working Capital | -3.89 | 20.97 | 15.77 | 7.26 | 51.26 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.